Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 2
1990 4
1991 3
1992 2
1993 2
1996 2
1997 4
1998 5
1999 2
2000 2
2001 4
2002 5
2003 3
2004 4
2005 2
2008 2
2009 2
2010 5
2011 3
2015 2
2016 1
2017 2
2018 3
2019 4
2020 5
2021 1
2022 6
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Enteric Toll-like receptor 7 stimulation causes acute exacerbation in lupus-susceptible mice.
Takase Y, Shirakashi M, Nishida Y, Katsushima M, Onizawa H, Hiwa R, Tsuji H, Kitagori K, Akizuki S, Onishi A, Nakashima R, Murakami K, Yoshifuji H, Tanaka M, Tsuruyama T, Morinobu A, Hashimoto M. Takase Y, et al. Among authors: shirakashi m. Clin Rheumatol. 2023 Apr;42(4):1185-1194. doi: 10.1007/s10067-022-06467-7. Epub 2022 Dec 14. Clin Rheumatol. 2023. PMID: 36515794
Factors associated with osteoporosis and fractures in patients with systemic lupus erythematosus: Kyoto Lupus Cohort.
Nakajima T, Doi H, Watanabe R, Murata K, Takase Y, Inaba R, Itaya T, Iwasaki T, Shirakashi M, Tsuji H, Kitagori K, Akizuki S, Nakashima R, Onishi A, Yoshifuji H, Tanaka M, Ito H, Hashimoto M, Ohmura K, Morinobu A. Nakajima T, et al. Among authors: shirakashi m. Mod Rheumatol. 2023 Dec 22;34(1):113-121. doi: 10.1093/mr/road014. Mod Rheumatol. 2023. PMID: 36680424
Comparisons of SLE-DAS and SLEDAI-2K and classification of disease activity based on the SLE-DAS with reference to patient-reported outcomes.
Onishi A, Tsuji H, Takase Y, Nakakubo Y, Iwasaki T, Kozuki T, Yoshida T, Shirakashi M, Onizawa H, Hiwa R, Kitagori K, Akizuki S, Nakashima R, Yoshifuji H, Tanaka M, Morinobu A. Onishi A, et al. Among authors: shirakashi m. Rheumatology (Oxford). 2023 Dec 1;62(12):3909-3915. doi: 10.1093/rheumatology/kead132. Rheumatology (Oxford). 2023. PMID: 36943365
Risk factors for the recurrence of relapsing polychondritis.
Yoshida T, Yoshifuji H, Shirakashi M, Nakakura A, Murakami K, Kitagori K, Akizuki S, Nakashima R, Ohmura K, Morinobu A. Yoshida T, et al. Among authors: shirakashi m. Arthritis Res Ther. 2022 May 30;24(1):127. doi: 10.1186/s13075-022-02810-0. Arthritis Res Ther. 2022. PMID: 35637525 Free PMC article.
Pathogenicity of IgG-Fc desialylation and its association with Th17 cells in an animal model of systemic lupus erythematosus.
Nishida Y, Shirakashi M, Hashii N, Nakashima R, Nakayama Y, Katsushima M, Watanabe R, Onizawa H, Hiwa R, Tsuji H, Kitagori K, Akizuki S, Onishi A, Murakami K, Yoshifuji H, Tanaka M, Tsuruyama T, Morinobu A, Hashimoto M. Nishida Y, et al. Among authors: shirakashi m. Mod Rheumatol. 2024 Mar 28;34(3):523-529. doi: 10.1093/mr/road054. Mod Rheumatol. 2024. PMID: 37300805
Autoantibody profiles associated with morbidity and mortality in scleroderma renal crisis.
Tsuji H, Kuramoto N, Sasai T, Shirakashi M, Onizawa H, Kitagori K, Akizuki S, Nakashima R, Watanabe R, Onishi A, Murakami K, Yoshifuji H, Tanaka M, Hashimoto M, Ohmura K, Morinobu A. Tsuji H, et al. Among authors: shirakashi m. Rheumatology (Oxford). 2022 Oct 6;61(10):4130-4135. doi: 10.1093/rheumatology/keac047. Rheumatology (Oxford). 2022. PMID: 35078211
92 results